How have ADIL shares performed in 2024?

Adial Pharmaceuticals' stock was trading at $1.86 at the beginning of 2024. Since then, ADIL stock has increased by 16.7% and is now trading at $2.17. View the best growth stocks for 2024 here .

Are investors shorting Adial Pharmaceuticals?

Adial Pharmaceuticals saw a decrease in short interest in March. As of March 31st, there was short interest totaling 8,700 shares, a decrease of 91.8% from the March 15th total of 105,600 shares. Based on an average daily volume of 3,830,000 shares, the short-interest ratio is presently 0.0 days. Currently, 0.2% of the shares of the company are short sold. View Adial Pharmaceuticals' Short Interest .

When is Adial Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, May 10th 2024. View our ADIL earnings forecast .

How were Adial Pharmaceuticals' earnings last quarter?

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) posted its quarterly earnings results on Wednesday, August, 11th. The company reported ($6.25) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($5.00) by $1.25.

When did Adial Pharmaceuticals' stock split?

Adial Pharmaceuticals shares reverse split before market open on Monday, August 7th 2023. The 1-25 reverse split was announced on Monday, August 7th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, August 7th 2023. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

What other stocks do shareholders of Adial Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Adial Pharmaceuticals investors own include Sorrento Therapeutics (SRNE) , Global Partners (GLP) , Corbus Pharmaceuticals (CRBP) , Aytu BioPharma (AYTU) , T2 Biosystems (TTOO) , AIM ImmunoTech (AIM) , Tandem Diabetes Care (TNDM) , vTv Therapeutics (VTVT) , Acasti Pharma (ACST) and Adamis Pharmaceuticals (ADMP) .

When did Adial Pharmaceuticals IPO?

Adial Pharmaceuticals (ADIL) raised $8 million in an initial public offering (IPO) on Friday, July 27th 2018. The company issued 1,500,000 shares at a price of $5.00 per share. Joseph Gunnar & Co. served as the underwriter for the IPO and Dawson James Securities was co-manager.

How do I buy shares of Adial Pharmaceuticals?

Shares of ADIL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:ADIL

Adial Pharmaceuticals (ADIL) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free ADIL Stock Alerts

$2.17

-0.15 (-6.47%)

(As of 04/18/2024 ET)

Compare

Today's Range: $2.12
▼
$2.30
50-Day Range: $0.83
▼
$3.26
52-Week Range: $0.76
▼
$14.00

Volume: 153,407 shs
Average Volume: 5.35 million shs
Market Capitalization: $8.79 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Get Adial Pharmaceuticals alerts:

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About Adial Pharmaceuticals Stock (NASDAQ:ADIL)

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.

ADIL Stock Price History

30 days | 90 days | 365 days | Advanced Chart

ADIL Stock News Headlines

April 11, 2024 | americanbankingnews.com

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Short Interest Update

April 11, 2024 | msn.com

Why Bitcoin-Linked MicroStrategy Along With Adial Pharmaceuticals, Alpine Immune Sciences, Marin Software, And Tesla Are On Investors' Radars Today

April 19, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

April 11, 2024 | msn.com

Dow Falls Over 1%; US Inflation Rate Accelerates In March

April 10, 2024 | marketwatch.com

Adial Pharmaceuticals Shares Rise 78% After Positive Trial Data for AD04

April 10, 2024 | msn.com

Adial stock rallies 81% on data for alcohol abuse drug

April 10, 2024 | investorplace.com

Why Is Adial Pharmaceuticals (ADIL) Stock Up 59% Today?

April 10, 2024 | msn.com

EXCLUSIVE: Adial Pharmaceuticals' Potential Treatment For Alcohol Use Disorder Shows Encouraging Safety, Patient Compliance

April 19, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

April 10, 2024 | finance.yahoo.com

Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use Disorder

April 10, 2024 | globenewswire.com

Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use Disorder

April 2, 2024 | globenewswire.com

Adial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and Provides Business Update

March 19, 2024 | investing.com

Adial Pharmaceuticals Inc (ADIL)

March 16, 2024 | finance.yahoo.com

MASI Apr 2024 120.000 call

March 16, 2024 | finance.yahoo.com

MASI Apr 2024 125.000 put

March 11, 2024 | benzinga.com

Peering Into Adial Pharmaceuticals's Recent Short Interest

March 1, 2024 | globenewswire.com

Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds

March 1, 2024 | investing.com

Adial Pharmaceuticals secures new patent for AD04 drug

February 28, 2024 | msn.com

Why Adial Pharmaceuticals Stock Is Blasting Off

February 28, 2024 | finanznachrichten.de

Adial Pharmaceuticals, Inc: Adial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark Office

February 28, 2024 | finance.yahoo.com

EXCLUSIVE: Adial Pharmaceuticals Secures New US Patent Covering Lead Product For Alcohol Use Disorder

February 28, 2024 | globenewswire.com

Adial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark Office

February 15, 2024 | finanznachrichten.de

Adial Pharmaceuticals, Inc.: Adial Pharmaceuticals to Present at the Winter Wrap-Up MicroCap Rodeo Conference on February 20

February 15, 2024 | finance.yahoo.com

Adial Pharmaceuticals to Present at the Winter Wrap-Up MicroCap Rodeo Conference on February 20

February 13, 2024 | finanznachrichten.de

Adial Pharmaceuticals, Inc: Adial Pharmaceuticals Awarded New Patent Notice of Allowance from the United States Patent and Trademark Office

February 13, 2024 | marketwatch.com

Adial Pharma Shares Rise 26% After Patent Notice of Allowance for AD04

February 13, 2024 | msn.com

EXCLUSIVE: Adial Pharmaceuticals Announces New US Patent Covering Its Molecular Genetic Diagnosing For Alcohol, Drug Dependence

See More Headlines

Receive ADIL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Adial Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 8/11/2021
Today: 4/19/2024
Next Earnings (Estimated): 5/10/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Current Symbol: NASDAQ:ADIL
CUSIP: N/A
CIK: 1513525
Web: www.adialpharma.com
Phone: (434) 422-9800
Fax: N/A
Employees: 16
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($5.72)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-5,120,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -250.52%
Return on Assets: -183.24%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 4.90
Quick Ratio: 4.90

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $2.46 per share
Price / Book: 0.88

Miscellaneous

Outstanding Shares: 4,050,000
Free Float: 3,468,000
Market Cap: $8.79 million
Optionable: No Data
Beta: 1.48

10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

Mr. Joseph A. M. Truluck M.B.A. (Age 46)
MBA, CFO, Treasurer & Secretary
Comp: $279.7k
Mr. Tony Goodman (Age 60)
COO & Director
Comp: $59k
Dr. Bankole A. Johnson DSc (Age 64)
FRCPsych, M.D., M.Phil, Ph.D., Founder & Chief Medical Officer
Comp: $375k
Mr. John R. Martin J.D.
General Counsel
Mr. Alex Lugovoy
Chief Business Officer
Dr. Jack W. Reich Ph.D. (Age 75)
Head of Regulatory
Comp: $17.01k
Mr. Mark H. Peikin
Chief Strategy Officer & Chief Development Officer
Ms. Catherine Fratila
Controller

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

ADIL Stock Analysis - Frequently Asked Questions

How have ADIL shares performed in 2024?: Adial Pharmaceuticals' stock was trading at $1.86 at the beginning of 2024. Since then, ADIL stock has increased by 16.7% and is now trading at $2.17.
View the best growth stocks for 2024 here.
Are investors shorting Adial Pharmaceuticals?: Adial Pharmaceuticals saw a decrease in short interest in March. As of March 31st, there was short interest totaling 8,700 shares, a decrease of 91.8% from the March 15th total of 105,600 shares. Based on an average daily volume of 3,830,000 shares, the short-interest ratio is presently 0.0 days. Currently, 0.2% of the shares of the company are short sold.
View Adial Pharmaceuticals' Short Interest.
When is Adial Pharmaceuticals' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Friday, May 10th 2024.
View our ADIL earnings forecast.
How were Adial Pharmaceuticals' earnings last quarter?: Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) posted its quarterly earnings results on Wednesday, August, 11th. The company reported ($6.25) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($5.00) by $1.25.

When did Adial Pharmaceuticals' stock split?: Adial Pharmaceuticals shares reverse split before market open on Monday, August 7th 2023. The 1-25 reverse split was announced on Monday, August 7th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, August 7th 2023. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.
What other stocks do shareholders of Adial Pharmaceuticals own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Adial Pharmaceuticals investors own include Sorrento Therapeutics (SRNE), Global Partners (GLP), Corbus Pharmaceuticals (CRBP), Aytu BioPharma (AYTU), T2 Biosystems (TTOO), AIM ImmunoTech (AIM), Tandem Diabetes Care (TNDM), vTv Therapeutics (VTVT), Acasti Pharma (ACST) and Adamis Pharmaceuticals (ADMP).
When did Adial Pharmaceuticals IPO?: Adial Pharmaceuticals (ADIL) raised $8 million in an initial public offering (IPO) on Friday, July 27th 2018. The company issued 1,500,000 shares at a price of $5.00 per share. Joseph Gunnar & Co. served as the underwriter for the IPO and Dawson James Securities was co-manager.
How do I buy shares of Adial Pharmaceuticals?: Shares of ADIL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:ADIL) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial